Spire Healthcare to Open New Cancer Care Centre in South West
Spire Healthcare has started work on a new £13 million cancer care centre in Bristol in a move that puts the hospital at the forefront of cancer care.
Reports show that incidents of cancer are continuing to rise rapidly and it is predicted that by 2020 almost half of Britons will get the disease .
Due to open in spring 2014, the multi-million pound development represents further significant investment by Spire in The Glen Hospital, Bristol - part of a total £30 million outlay in the past five years .
This new centre, based in Aztec West, is being built to offer greater provision of cancer care in the region and will relieve strain on the NHS as further budget cuts are anticipated.
Rob Anderson, Hospital Director, said: “In the UK the current capacity for cancer care is not enough to keep up with demand. If we don’t act now then we will be facing a significant shortfall.”
“We’re fitting this facility with some of the most advanced technology on the market, including a state-of-the-art linear accelerator. This equipment will enable our clinicians to provide highly targeted radiotherapy, which means much greater precision for patients as healthy tissue surrounding tumours is preserved.”
Rob continued: “The site is easily accessible from the South West and Wales and it’s located close to the motorway network. At Spire Bristol we already provide support to people with cancer, but this facility will enable us to offer integrated end to end care for patients from diagnosis right through to recovery.”
The facility will offer a range of services and will largely treat breast, prostate, rectal and lung cancers.
Neil McCullough, Spire Healthcare’s Business Development Director said: “We’re very excited to be developing our first cancer centre in Bristol. As the population ages and cancer incidence increases, Spire is committed to offering high quality, patient-focused, cancer care that will now include the very latest radiotherapy technology.”
Spire is aiming for the facility to be its first Centre of Excellence for cancer care.